279.122 Billion USD
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Zacks Investment Research 11:17 07/12/2022
4 Defensive Stocks to Prepare Your Portfolio for a Recession
Amid the rising possibility of a recession, defensive stocks wit...
Investors Business Daily 16:23 06/12/2022
Is Merck Stock A Buy After Surging To A Fresh High On Its Imago Buyout Plans?
Is Merck stock a buy after the company announced its acquisition...
Zacks Investment Research 12:02 05/12/2022
GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe
GSK's new drug application (NDA) for momelotinib is under standa...
The Motley Fool 06:07 03/12/2022
What Bear Market? This Top-Performing Dow Stock Has Thrived in 2022.
The company is having a record-smashing year.